Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth
- Written by PR Newswire
![]() |
MELBOURNE, Australia and INDIANAPOLIS, Aug. 21, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the half-year ended 30 June 2025. All figures are in USD unless stated otherwise.
H1 2025 key results[1]
Group performance[2]: Reflects strategic investm...








